206 related articles for article (PubMed ID: 23640750)
1. Clinical significance of cell cycle inhibitors in hepatocellular carcinoma.
Matsuda Y; Wakai T; Kubota M; Takamura M; Yamagiwa S; Aoyagi Y; Osawa M; Fujimaki S; Sanpei A; Genda T; Ichida T
Med Mol Morphol; 2013 Dec; 46(4):185-92. PubMed ID: 23640750
[TBL] [Abstract][Full Text] [Related]
2. Molecular mechanism underlying the functional loss of cyclindependent kinase inhibitors p16 and p27 in hepatocellular carcinoma.
Matsuda Y
World J Gastroenterol; 2008 Mar; 14(11):1734-40. PubMed ID: 18350604
[TBL] [Abstract][Full Text] [Related]
3. p16 and p27 are functionally correlated during the progress of hepatocarcinogenesis.
Matsuda Y; Ichida T
Med Mol Morphol; 2006 Dec; 39(4):169-75. PubMed ID: 17187177
[TBL] [Abstract][Full Text] [Related]
4. Loss of p16 contributes to p27 sequestration by cyclin D(1)-cyclin-dependent kinase 4 complexes and poor prognosis in hepatocellular carcinoma.
Matsuda Y; Ichida T; Genda T; Yamagiwa S; Aoyagi Y; Asakura H
Clin Cancer Res; 2003 Aug; 9(9):3389-96. PubMed ID: 12960127
[TBL] [Abstract][Full Text] [Related]
5. Expression and prognostic roles of the G1-S modulators in hepatocellular carcinoma: p27 independently predicts the recurrence.
Ito Y; Matsuura N; Sakon M; Miyoshi E; Noda K; Takeda T; Umeshita K; Nagano H; Nakamori S; Dono K; Tsujimoto M; Nakahara M; Nakao K; Taniguchi N; Monden M
Hepatology; 1999 Jul; 30(1):90-9. PubMed ID: 10385644
[TBL] [Abstract][Full Text] [Related]
6. Hepatocyte growth factor induces redistribution of p21(CIP1) and p27(KIP1) through ERK-dependent p16(INK4a) up-regulation, leading to cell cycle arrest at G1 in HepG2 hepatoma cells.
Han J; Tsukada Y; Hara E; Kitamura N; Tanaka T
J Biol Chem; 2005 Sep; 280(36):31548-56. PubMed ID: 16014626
[TBL] [Abstract][Full Text] [Related]
7. CACYBP Enhances Cytoplasmic Retention of P27
Lian YF; Huang YL; Zhang YJ; Chen DM; Wang JL; Wei H; Bi YH; Jiang ZW; Li P; Chen MS; Huang YH
Theranostics; 2019; 9(26):8392-8408. PubMed ID: 31754404
[TBL] [Abstract][Full Text] [Related]
8. Loss of p16 and p27 is associated with progression of human gastric cancer.
Myung N; Kim MR; Chung IP; Kim H; Jang JJ
Cancer Lett; 2000 May; 153(1-2):129-36. PubMed ID: 10779641
[TBL] [Abstract][Full Text] [Related]
9. Expression of the G1-S modulators in hepatitis B virus-related hepatocellular carcinoma and dysplastic nodule: association of cyclin D1 and p53 proteins with the progression of hepatocellular carcinoma.
Choi YL; Park SH; Jang JJ; Park CK
J Korean Med Sci; 2001 Aug; 16(4):424-32. PubMed ID: 11511787
[TBL] [Abstract][Full Text] [Related]
10. Disruption of the p16/cyclin D1/retinoblastoma protein pathway in the majority of human hepatocellular carcinomas.
Azechi H; Nishida N; Fukuda Y; Nishimura T; Minata M; Katsuma H; Kuno M; Ito T; Komeda T; Kita R; Takahashi R; Nakao K
Oncology; 2001; 60(4):346-54. PubMed ID: 11408803
[TBL] [Abstract][Full Text] [Related]
11. Predictors of ribociclib-mediated antitumour effects in native and sorafenib-resistant human hepatocellular carcinoma cells.
Reiter FP; Denk G; Ziesch A; Ofner A; Wimmer R; Hohenester S; Schiergens TS; Spampatti M; Ye L; Itzel T; Munker S; Teufel A; Gerbes AL; Mayerle J; De Toni EN
Cell Oncol (Dordr); 2019 Oct; 42(5):705-715. PubMed ID: 31250364
[TBL] [Abstract][Full Text] [Related]
12. Multifaceted regulation of cell cycle progression by estrogen: regulation of Cdk inhibitors and Cdc25A independent of cyclin D1-Cdk4 function.
Foster JS; Henley DC; Bukovsky A; Seth P; Wimalasena J
Mol Cell Biol; 2001 Feb; 21(3):794-810. PubMed ID: 11154267
[TBL] [Abstract][Full Text] [Related]
13. Aberrant cell cycle regulation in cervical carcinoma.
Kim YT; Zhao M
Yonsei Med J; 2005 Oct; 46(5):597-613. PubMed ID: 16259056
[TBL] [Abstract][Full Text] [Related]
14. Expression of p27, cyclin E and cyclin A in hepatocellular carcinoma and its clinical significance.
Zhou Q; He Q; Liang LJ
World J Gastroenterol; 2003 Nov; 9(11):2450-4. PubMed ID: 14606074
[TBL] [Abstract][Full Text] [Related]
15. Silibinin efficacy against human hepatocellular carcinoma.
Varghese L; Agarwal C; Tyagi A; Singh RP; Agarwal R
Clin Cancer Res; 2005 Dec; 11(23):8441-8. PubMed ID: 16322307
[TBL] [Abstract][Full Text] [Related]
16. Cell proliferation, apoptosis and the related regulators p27, p53 expression in hepatocellular carcinoma.
Jing Z; Nan KJ; Hu ML
World J Gastroenterol; 2005 Apr; 11(13):1910-6. PubMed ID: 15800979
[TBL] [Abstract][Full Text] [Related]
17. Induced expression of p16(INK4a) inhibits both CDK4- and CDK2-associated kinase activity by reassortment of cyclin-CDK-inhibitor complexes.
McConnell BB; Gregory FJ; Stott FJ; Hara E; Peters G
Mol Cell Biol; 1999 Mar; 19(3):1981-9. PubMed ID: 10022885
[TBL] [Abstract][Full Text] [Related]
18. Acquired expression of p27 is a favorable prognostic indicator in patients with hepatocellular carcinoma.
Fiorentino M; Altimari A; D'Errico A; Cukor B; Barozzi C; Loda M; Grigioni WF
Clin Cancer Res; 2000 Oct; 6(10):3966-72. PubMed ID: 11051245
[TBL] [Abstract][Full Text] [Related]
19. SKP2 and CKS1 promote degradation of cell cycle regulators and are associated with hepatocellular carcinoma prognosis.
Calvisi DF; Ladu S; Pinna F; Frau M; Tomasi ML; Sini M; Simile MM; Bonelli P; Muroni MR; Seddaiu MA; Lim DS; Feo F; Pascale RM
Gastroenterology; 2009 Nov; 137(5):1816-26.e1-10. PubMed ID: 19686743
[TBL] [Abstract][Full Text] [Related]
20. Expression of p27 and p16 and their clinical significance in gastric cancer.
Kumari S; Kumar P; Kumar M; Singh S; Narayan G
Clin Transl Oncol; 2021 Apr; 23(4):856-865. PubMed ID: 32880047
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
